Human papillomavirus 16 E7 peptide
Term · Oncology and biomedicine · MLC-T-ONC-014248
A synthetic peptide sequence of human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas.
| Identifier | MLC-T-ONC-014248 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | HPV-16 E7; HPV16 E7 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014248",
"term": "Human papillomavirus 16 E7 peptide",
"field": "Oncology and biomedicine",
"definition": "A synthetic peptide sequence of human papillomavirus (HPV) E7 nuclear protein which is used to produce vaccines against HPV infection and HPV-related neoplasms. HPV E7 oncogenic protein binds the retinoblastoma tumor suppressor protein, pRB, as well as a number of other cellular proteins, and serves as a transcriptional activator. This protein is important in the induction and maintenance of cellular transformation and is co-expressed in the majority of HPV-containing carcinomas.",
"synonyms": [
"HPV-16 E7",
"HPV16 E7"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/human-papillomavirus-16-e7-peptide/"
}
Record 8,753 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.